Insulin-like growth factor-1 and its binding proteins during a low-protein diet in chronic renal failure.

The effects of a low-protein diet on the serum insulin-like growth factor (IGF)-1 and IGF binding proteins (IGFBP) were investigated during a 3-month controlled study in 12 adult chronic renal failure patients. Six patients were randomly supplemented with keto acids (Cetolog, Clintec, Velizy, France). Protein intake was prescribed so that both groups were isonitrogenous. Dietary survey included a monthly 3-day food record and a 24-h urinary urea measurement. After a 4- to 6-wk equilibrium period (1.11 g of protein, 32 kcal/kg body wt per day), patients reduced their protein intake to 0.71 g protein/kg body wt per day. Energy intake was kept constant (31 kcal/kg body wt per day) during the 3-month period. Serum IGF-1 levels were in normal range and, for 11 of the 12 patients, were correlated with the GFR (P = 0.01). These serum IGF-1 values did not decrease after reducing the protein intake. By Western ligand blotting, serum IGFBP1, IGFBP2, and IGFBP4 levels were significantly higher than normal adults, whereas the IGFBP3 level was not increased. IGFBP were not modified when protein intake was reduced. The IGFBP1 level was elevated despite a normal insulin level. IGFBP4 changes were inversely correlated with IGF-1 variations. There was no difference between groups receiving or not receiving the keto acids. Thus, in adult chronic renal failure, reducing protein intake by 40% did not modify the growth hormone/IGF-1/IGFBP axis.

[1]  D. Fouque,et al.  Pharmacokinetics of recombinant human insulin-like growth factor-1 in dialysis patients. , 1995, Kidney international.

[2]  R. Rosenfeld,et al.  Alteration in insulin-like growth factor-binding proteins (IGFBPs) and IGFBP-3 protease activity in serum and urine from acute and chronic renal failure. , 1994, The Journal of clinical endocrinology and metabolism.

[3]  M. Binoux,et al.  In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. , 1994, The Journal of clinical investigation.

[4]  M. Binoux,et al.  Insulin-like growth factor binding protein-3 is functionally altered in pregnancy plasma. , 1994, Endocrinology.

[5]  J. Holly,et al.  Insulin-like growth factor binding proteins: a review of methodological aspects of their purification, analysis and regulation. , 1994, Growth regulation.

[6]  J. Ketelslegers,et al.  Nutritional regulation of the insulin-like growth factors. , 1994, Endocrine reviews.

[7]  D. Clemmons,et al.  The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis. , 1993, The Journal of clinical endocrinology and metabolism.

[8]  B. Tönshoff,et al.  Efficacy and safety of growth hormone treatment in short children with renal allografts: Three year experience , 1993 .

[9]  L. Phillips,et al.  Differential regulation of IGF-1 and IGF-binding protein-1 by dietary composition in humans. , 1993, The American journal of the medical sciences.

[10]  M D Jensen,et al.  Insulin regulation of insulin-like growth factor binding protein-1 in obese and nonobese humans. , 1992, The Journal of clinical endocrinology and metabolism.

[11]  J. Holly,et al.  The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. , 1991, The Journal of endocrinology.

[12]  W. Mitch,et al.  Dietary protein restriction in patients with chronic renal failure. , 1991, Kidney international.

[13]  A. Hoffman,et al.  Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4. , 1991, Endocrinology.

[14]  Y. Le Bouc,et al.  Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance. , 1989, The Journal of clinical endocrinology and metabolism.

[15]  N. Ferrara,et al.  Dietary compliance to a low protein and phosphate diet in patients with chronic renal failure. , 1989, Kidney international. Supplement.

[16]  D. Powell,et al.  IGF Binding Proteins in Growth-Retarded Children with Chronic Renal Failure , 1989, Pediatric Research.

[17]  J. Ketelslegers,et al.  Early changes in serum concentrations of somatomedin-C induced by dietary protein deprivation in rats: contributions of growth hormone receptor and post-receptor defects. , 1988, The Journal of endocrinology.

[18]  J. Ketelslegers,et al.  Decreased serum insulin-like growth factor I response to growth hormone in hypophysectomized rats fed a low protein diet: evidence for a postreceptor defect. , 1988, Acta endocrinologica.

[19]  M. Binoux,et al.  Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. , 1986, Analytical biochemistry.

[20]  A. M. Nahas,et al.  DIETARY TREATMENT OF CHRONIC RENAL FAILURE: TEN UNANSWERED QUESTIONS , 1986, The Lancet.

[21]  M. Binoux,et al.  Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels. , 1984, The Journal of clinical endocrinology and metabolism.

[22]  D. Clemmons,et al.  Dietary components that regulate serum somatomedin-C concentrations in humans. , 1983, The Journal of clinical investigation.

[23]  B. Brenner,et al.  Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. , 1982, The New England journal of medicine.

[24]  L. Phillips,et al.  Circulating somatomedin activity and sulfate levels in adults with normal and impaired kidney function. , 1981, Metabolism: clinical and experimental.

[25]  C. Combe,et al.  Compliance and effects of nutritional treatment on progression and metabolic disorders of chronic renal failure. , 1993, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  B. Beaufrère,et al.  Increase of circulating insulin-like growth factor-I in chronic renal failure is reduced by low-protein diet. , 1992, Mineral and electrolyte metabolism.

[27]  W. Mitch,et al.  A method for estimating nitrogen intake of patients with chronic renal failure. , 1985, Kidney international.

[28]  M. Labeeuw,et al.  Acute effect of high dose (48 mg) of piretanide in advanced renal insufficiency. , 1981, British journal of clinical pharmacology.